These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis. Parasa S; Desai M; Vittal A; Chandrasekar VT; Pervez A; Kennedy KF; Gupta N; Shaheen NJ; Sharma P Gut; 2019 Dec; 68(12):2122-2128. PubMed ID: 30872393 [TBL] [Abstract][Full Text] [Related]
3. Systematic review with meta-analysis: prevalent vs. incident oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus. Visrodia K; Singh S; Krishnamoorthi R; Ahlquist DA; Wang KK; Iyer PG; Katzka DA Aliment Pharmacol Ther; 2016 Oct; 44(8):775-84. PubMed ID: 27562355 [TBL] [Abstract][Full Text] [Related]
4. Post-endoscopy Barrett's neoplasia after a negative index endoscopy: a systematic review and proposal for definitions and performance measures in endoscopy. Desai M; Lieberman D; Srinivasan S; Nutalapati V; Challa A; Kalgotra P; Sundaram S; Repici A; Hassan C; Kaminski MF; Sharma P Endoscopy; 2022 Sep; 54(9):881-889. PubMed ID: 34979570 [TBL] [Abstract][Full Text] [Related]
5. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207 [TBL] [Abstract][Full Text] [Related]
6. External validation of a model to determine risk of progression of Barrett's oesophagus to neoplasia. Kunzmann AT; Thrift AP; Johnston BT; McManus DT; Gavin AT; Turkington RC; Coleman HG Aliment Pharmacol Ther; 2019 May; 49(10):1274-1281. PubMed ID: 30950101 [TBL] [Abstract][Full Text] [Related]
7. Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study. Timmer MR; Martinez P; Lau CT; Westra WM; Calpe S; Rygiel AM; Rosmolen WD; Meijer SL; Ten Kate FJ; Dijkgraaf MG; Mallant-Hent RC; Naber AH; van Oijen AH; Baak LC; Scholten P; Böhmer CJ; Fockens P; Maley CC; Graham TA; Bergman JJ; Krishnadath KK Gut; 2016 Oct; 65(10):1602-10. PubMed ID: 26104750 [TBL] [Abstract][Full Text] [Related]
8. Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus. Waterhouse DJ; Januszewicz W; Ali S; Fitzgerald RC; di Pietro M; Bohndiek SE Cancer Res; 2021 Jun; 81(12):3415-3425. PubMed ID: 34039635 [TBL] [Abstract][Full Text] [Related]
9. Diagnosing dysplasia in Barrett's oesophagus still requires Seattle protocol biopsy in the era of modern video endoscopy: results from a tertiary centre Barrett's dysplasia database. Nachiappan A; Ragunath K; Card T; Kaye P Scand J Gastroenterol; 2020 Jan; 55(1):9-13. PubMed ID: 31880176 [No Abstract] [Full Text] [Related]
10. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Pohl H; Rösch T; Vieth M; Koch M; Becker V; Anders M; Khalifa AC; Meining A Gut; 2008 Dec; 57(12):1648-53. PubMed ID: 18755886 [TBL] [Abstract][Full Text] [Related]
11. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance. Rana PS; Johnston DA Dis Esophagus; 2000; 13(1):28-31. PubMed ID: 11005328 [TBL] [Abstract][Full Text] [Related]
12. Neoplasia Detection Rate in Barrett's Esophagus and Its Impact on Missed Dysplasia: Results from a Large Population-Based Database. Dhaliwal L; Codipilly DC; Gandhi P; Johnson ML; Lansing R; Wang KK; Leggett CL; Katzka DA; Iyer PG Clin Gastroenterol Hepatol; 2021 May; 19(5):922-929.e1. PubMed ID: 32707339 [TBL] [Abstract][Full Text] [Related]
13. [Surveillance for Barrett's oesophagus: worthwhile?]. Kastelein F; Kuipers EJ Ned Tijdschr Geneeskd; 2012; 156(49):A5497. PubMed ID: 23218039 [TBL] [Abstract][Full Text] [Related]
14. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review. Qumseya BJ; Wang H; Badie N; Uzomba RN; Parasa S; White DL; Wolfsen H; Sharma P; Wallace MB Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1562-70.e1-2. PubMed ID: 23851020 [TBL] [Abstract][Full Text] [Related]
15. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance? Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485 [TBL] [Abstract][Full Text] [Related]
16. Surveillance in Barrett's esophagus: an audit of practice. Ajumobi A; Bahjri K; Jackson C; Griffin R Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878 [TBL] [Abstract][Full Text] [Related]
17. Incidence of adenocarcinoma among patients with Barrett's esophagus. Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385 [TBL] [Abstract][Full Text] [Related]
18. Endoscopic eradication therapy for Barrett's oesophagus: state of the art. Kolb JM; Wani S Curr Opin Gastroenterol; 2020 Jul; 36(4):351-358. PubMed ID: 32487852 [TBL] [Abstract][Full Text] [Related]
19. Confocal laser endomicroscopy for in vivo diagnosis of Barrett's oesophagus and associated neoplasia: a pilot study conducted in a single Italian centre. Trovato C; Sonzogni A; Ravizza D; Fiori G; Tamayo D; De Roberto G; de Leone A; De Lisi S; Crosta C Dig Liver Dis; 2013 May; 45(5):396-402. PubMed ID: 23352281 [TBL] [Abstract][Full Text] [Related]